U.S. Invests $232 Million to Produce At-Home Covid-19 Tests

Date Published02/01/2021
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Ellume USA LLC
Parent companyEllume Ltd.
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Total number of jobs (added or to be added):1500
Year reshoring announced:2021
Year reshoring implemented or to be implemented:2021
Domestically, the work will be done:In-house
Capital investment ($):231.8
Country(ies) from which reshored:Australia
City reshored to:Frederick
State(s) reshored to:MD
If relevant, work nearshored to:-
Product(s) reshoredhome Covid-19 tests
What non-domestic negative factors made offshoring less attractive?Supply chain interruption risk/Natural disaster risk/Political instability , Total cost
What domestic positive factors made reshoring more attractive?Impact on domestic economy, Biden, covid-19
Find Reshoring Articles